Holen Sie sich die Stockscreener-App
4.645
15.55%
-0.855
Schlusskurs vom Vortag:
$5.50
Offen:
$5.46
24-Stunden-Volumen:
74,901
Relative Volume:
1.07
Marktkapitalisierung:
$1.60M
Einnahmen:
$15.74M
Nettoeinkommen (Verlust:
$-12.86M
KGV:
-0.0201
EPS:
-231.1302
Netto-Cashflow:
$-8.71M
1W Leistung:
-26.50%
1M Leistung:
-65.34%
6M Leistung:
-98.34%
1J Leistung:
-96.48%
1-Tages-Spanne:
$4.6201
$5.53
1-Wochen-Bereich:
$4.6201
$7.32
52-Wochen-Spanne:
$4.6201
$3,360.00
22nd Century Group, Inc. Stock (XXII) Company Profile
Firmenname
22nd Century Group, Inc.
Sektor
Branche
Telefon
716-270-1523
Adresse
8560 Main Street, Williamsville, NY
Compare XXII vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
4.645 | 1.60M | 15.74M | -12.86M | -8.71M | -231.13 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-07-21 | Eingeleitet | Alliance Global Partners | Buy |
| 2022-06-15 | Eingeleitet | Craig Hallum | Buy |
| 2022-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-07-23 | Eingeleitet | Cowen | Outperform |
| 2017-10-16 | Bestätigt | Chardan Capital Markets | Buy |
| 2016-08-11 | Bestätigt | Chardan Capital Markets | Buy |
Alle ansehen
22nd Century Group, Inc. Aktie (XXII) Neueste Nachrichten
22nd Century Group Inc (XXII) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
22nd Century Group Inc (XXII) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
22nd Century Group Inc (XXII) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
22nd Century Group Inc (XXII) Institutional Confidence - TradingKey
22nd Century Group Inc (XXII) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
22nd Century Group Inc (XXII) Valuation: PE, PB & Fair Value Analysis - TradingKey
22nd Century Group Inc (XXII) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
22nd Century Group Inc (XXII) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
22nd Century Group Inc (XXII) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
XXII News | 22ND CENTURY GROUP INC (NASDAQ:XXII) - ChartMill
3.02M warrant shares registered for resale by 22nd Century (XXII) - Stock Titan
Shareholder voting outcomes at 22nd Century Group (NASDAQ: XXII) - Stock Titan
22nd Century Group announces warrant inducement and 1-for-20 reverse stock split By Investing.com - Investing.com Australia
Warrant inducement and 1-for-20 reverse split at 22nd Century Group (XXII) - Stock Titan
22nd Century Group announces warrant inducement and 1-for-20 reverse stock split - Investing.com UK
22nd Century Raises $0.46M via Warrant Inducement, Redeems $2.01M Preferred; Hires Dawson James - TradingView
22nd Century (NASDAQ: XXII) sets warrant inducement and 1-for-20 split - Stock Titan
XXII Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
XXII Stock Chart | 22ND CENTURY GROUP INC (NASDAQ:XXII) - ChartMill
22nd Century launches VLN cigarettes in California stores - Investing.com UK
22nd Century launches VLN cigarettes in California stores By Investing.com - Investing.com South Africa
22nd Century Group (Nasdaq: XXII) Launches Pinnacle VLN® Trial in California, Opening Another Major New State for Reduced-Nicotine Cigarettes - The Manila Times
FDA-authorized low-nicotine cigarettes begin California test run - Stock Titan
XXII Stock Price, Quote & Chart | 22ND CENTURY GROUP INC (NASDAQ:XXII) - ChartMill
22nd Century Group (Nasdaq: XXII) Expands High-Margin Pinnacle Platform With Launch of Pinnacle Pure at Major U.S. Retailers - Sahm
22nd Century Group (Nasdaq: XXII) Expands High-Margin - GlobeNewswire
22nd Century Group, IncCommon Stock (NQ: XXII - FinancialContent
22nd Century Group Expands Distribution of VLN® Cigarettes to 150 New Locations in Metro New York and Northern New Jersey - Quiver Quantitative
22nd Century Group (Nasdaq: XXII) Ignites Major VLN® Retail Expansion in Metro New York and Northern New Jersey Under Pinnacle Brand - The Manila Times
22nd Century Group (Nasdaq: XXII) Ignites Major VLN Retail Expansion in Metro New York and Northern New Jersey Under Pinnacle Brand - Moomoo
22nd Century Group, Inc. (NASDAQ:XXII) Q1 2026 Earnings Call Transcript - Insider Monkey
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications - 2Firsts
22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Review - The Manila Times
22nd Century Group Seeks FDA Renewal for VLN® as Modified Risk Tobacco Product - geneonline.com
XXII | 22nd Century Group Inc. FinancialsIncome Statement - Quiver Quantitative
22nd Century Group Seeks Renewal of Modified Risk Tobacco Product Status for VLN® King and VLN® Menthol King Cigarettes - Quiver Quantitative
Cigarettes with 95% less nicotine face new FDA review - Stock Titan
Fda to review two modified risk tobacco product renewal applications from 22nd Century Group - marketscreener.com
FDA To Review Two Modified Risk Tobacco Product Renewal Applications From 22nd Century Group - TradingView
22nd Century slightly lowers first-quarter loss; no net revenue from very-low-nicotine cigarettes - Winston-Salem Journal
FDA Files MRTP Renewal for Two 22nd Century Products - Tobacco Reporter
XXII Q1 2026 Earnings Call Transcript - The Globe and Mail
MSN Money - MSN
Number of shareholders of 22nd Century Group, Inc – NASDAQ:XXII - TradingView
22Nd Century Group IncQ1 Net Revenues Incr - Moomoo
Q1 2026 22nd Century Group Inc Earnings Call Transcript - GuruFocus
22nd Century Group, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
22nd Century: Q1 Earnings Snapshot - theheraldreview.com
Finanzdaten der 22nd Century Group, Inc.-Aktie (XXII)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):